Epiphyseal growth plate growth hormone receptor signaling is decreased in chronic kidney disease-related growth retardation

Kidney International

Volumn 84, Issue 5, 2013, Pages 940-949

  Troib, Ariel ^a   Landau, Daniel ^b   Kachko, Leonid ^b   Rabkin, Ralph ^c,d   Segev, Yael ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Veterans Affairs Health Care Palo Alto   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

chronic kidney disease; growth hormone; growth plate; IGF I; receptor; somatotropin; STAT5

Indexed keywords

GROWTH HORMONE RECEPTOR; JANUS KINASE 2; MESSENGER RNA; SOMATOMEDIN C; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GROWTH HORMONE BLOOD LEVEL; GROWTH PLATE; GROWTH RETARDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOCS2 GENE; UPREGULATION; VEGF GENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GROWTH DISORDERS; GROWTH HORMONE; GROWTH PLATE; INSULIN-LIKE GROWTH FACTOR I; JANUS KINASE 2; KIDNEY; MALE; NEPHRECTOMY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIBIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888324447     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.196     Document Type: Article

References (48)

1. Mahesh S, Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol 2008; 23: 41-48.
2. Fine RN. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective. Pediatr Nephrol 2010; 25: 725-732.
3. Webb EA, Dattani MT. Diagnosis of growth hormone deficiency. Endocr Dev 2010; 18: 55-66.
4. Gevers EF, Hannah MJ, Waters MJ et al. Regulation of rapid signal transducer and activator of transcription-5 phosphorylation in the resting cells of the growth plate and in the liver by growth hormone and feeding. Endocrinology 2009; 150: 3627-3636.
5. Mak RH, Cheung WW, Roberts CT Jr. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 2008; 18: 17-25.
6. Gat-Yablonski G, Yackobovitch-Gavan M, Phillip M. Nutrition and bone growth in pediatrics. Endocrinol Metab Clin North Am 2009; 38: 565-586.
7. Nilsson O, Marino R, De Luca F et al. Endocrine regulation of the growth plate. Horm Res 2005; 64: 157-165.
8. Mackie EJ, Ahmed YA, Tatarczuch L et al. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 2008; 40: 46-62.
9. Hunziker EB, Wagner J, Zapf J. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 1994; 93: 1078-1086.
10. Sun DF, Zheng Z, Tummala P et al. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 2004; 15: 2630-2636.
11. Schaefer F, Chen Y, Tsao T et al. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. J Clin Invest 2001; 108: 467-475.
12. Landau D, Eshet R, Troib A et al. Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation. Endocrine 2009; 36: 126-134.
13. Leucht P, Kim JB, Wazen R et al. Effect of mechanical stimuli on skeletal regeneration around implants. Bone 2007; 40: 919-930.
14. David A, Hwa V, Metherell LA et al. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev 2011; 32: 472-497.
15. Tonshoff B, Kiepe D, Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 2005; 20: 279-289.
16. Santos F, Carbajo-Pérez E, Rodŕguez J et al. Alterations of the growth plate in chronic renal failure. Pediatr Nephrol 2005; 3: 330-334.
17. Tonshoff B, Blum WF, Mehls O. Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int 1997; 58(Suppl): S106-S113.
18. Tonshoff B, Powell DR, Zhao D et al. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and-2 gene expression in experimental uremia. Endocrinology 1997; 138: 938-946.
19. Edmondson SR, Baker NL, Oh J et al. Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int 2000; 58: 62-70.
20. Green H, Morikawa M, Nixon T. A dual effector theory of growth-hormone action. Differentiation 1985; 29: 195-198.
21. Ohlsson C, Lindahl A, Isgaard J et al. The dual effector theory. Compr Physiol 2011; (Suppl): 24: S501-S514.
22. Butler AA, Yakar S, LeRoith D. Insulin-like growth factor-I: compartmentalization within the somatotropic axis News Physiol Sci 2002; 17: 82-85.
23. Nilsson O, Marino R, De Luca F et al. Endocrine regulation of the growth plate. Horm Res 2005; 64: 157-165.
24. Mackie EJ, Tatarczuch L, Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 2011; 211: 109-121.
25. Wu S, Morrison A, Sun H et al. Nuclear factor-kappaB (NF-kappaB) p65 interacts with Stat5b in growth plate chondrocytes and mediates the effects of growth hormone on chondrogenesis and on the expression of insulin-like growth factor-1 and bone morphogenetic protein-2. J Biol Chem 2011; 286: 24726-24734.
26. Sims NA, Clement-Lacroix P, Da Ponte F et al. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 2000; 106: 1095-1103.
27. Udy GB, Towers RP, Snell RG et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997; 14: 7239-7244.
28. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423: 332-336.
29. Sanchez CP, Salusky IB, Kuizon BD et al. Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 1998; 54: 1879-1887.
30. Mehls O, Himmele R, Homme M et al. The interaction of glucocorticoids with the growth hormone-insulin-like growth factor axis and its effects on growth plate chondrocytes and bone cells. J Pediatr Endocrinol Metab 2001; 14(Suppl): S1475-S1482.
31. Gil-Pena H, Garcia-Lopez E, Alvarez-Garcia O et al. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growthretarded hypokalemic rats: effect of growth hormone treatment. Am J Physiol Renal Physiol 2009; 297: 639-645.
32. Vesterlund M, Zadjali F, Persson T et al. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One 2011; 6: 25358.
33. Pass C, MacRae VE, Ahmed SF et al. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Cell Biochem Funct 2009; 27: 119-127.
34. Chen Y, Sood S, Biada J et al. Increased workload fully activates the blunted IRS-1/PI3-kinase/Akt signaling pathway in atrophied uremic muscle. Kidney Int 2008; 73: 848-855.
35. Cheung WW, Rosengren S, Boyle DL et al. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int 2008; 74: 180-186.
36. Chen Y, Sun D, Krishnamurthy VM et al. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding. Am J Physiol Endocrinol Metab 2007; 292: 1856-1862.
37. Zyga S, Christopoulou G, Malliarou M. Malnutrition-inflammationatherosclerosis syndrome in patients with end-stage renal disease. J Ren Care 2011; 37: 12-15.
38. Yilmaz MI, Solak Y, Covic A et al. Renal anemia of inflammation: the name is self-explanatory. Blood Purif 2011; 32: 220-225.
39. Bergstrom J, Lindholm B, Lacson E Jr et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients Semin Dial 2000; 13: 163-175.
40. Kiepe D, Ulinski T, Powell DR et al. Differential effects of insulin like growth factor binding proteins-1,-2,-3, and-6 on cultured growth platechondrocytes. Kidney Int 2002; 5: 1591-1600.
41. Bailey JL, Zheng B, Hu Z et al. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 2006; 5: 1388-1394.
42. Hirschberg R, Rabb H, Bergamo R et al. The delayed effect of growth hormone on renal function in humans. Kidney Int 1989; 35: 865-870.
43. Fisher MC, Meyer C, Garber G et al. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth. Bone 2005; 6: 741-750.
44. Amil B, Fernandez-Fuente M, Molinos I et al. Chondromodulin-I expression in the growth plate of young uremic rats. Kidney Int 2004; 66: 51-59.
45. Sanchez CP, He YZ. Bone growth during rapamycin therapy in young rats. BMC Pediatr 2009; 9: 3.
46. Mak RH, Pak YK. End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int 1996; 50: 400-406.
47. Dudley AC, Thomas D, Best J et al. A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem J 2005; 390: 427-436.
48. Fleck C, Appenroth D, Jonas P et al. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats-Influence of sex, strain, and surgical procedure. Exp Toxicol Pathol 2006; 3: 195-205.